Variecolactone, a Natural PDE4 Inhibitor from Marine-Derived Talaromyces sp. ZSD-1, Alleviates Amyloid-β Accumulation and mtDNA Dyshomeostasis via cAMP-PKA-CREB Signaling Pathway
Biomolecules · 12.04.2026 · 16 (4) · 570
DOI: 10.3390/biom16040570 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 12.04.2026. Verfasst von Tingting Fu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou 570225, China. Hauptthemen laut MEDLINE: Amyloid beta-Peptides, Phosphodiesterase 4 Inhibitors, DNA, Mitochondrial, Sesterterpenes. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hainan Provincial Natural Science Foundation of China, National Natural Science Foundation of China, Natural Science Foundation of China.
Abstract (Originalsprache)
Alzheimer’s disease (AD) is characterized by amyloid-β deposition, neuroinflammation, and mitochondrial dysfunction. Phosphodiesterase 4 (PDE4), a key regulator of cyclic nucleotides in neurons, represents a promising therapeutic target for AD. In this study, we performed a PDE4 inhibition-guided screen of an in-house marine natural product library derived from marine fungi, leading to the identification of a sesterterpenoid variecolactone (VLT) as a potent PDE4 inhibitor. VLT exhibited selective PDE4D inhibition (IC50 = 2.302 μM) with minimal activity against other PDE subtypes. Further mechanical investigation revealed that VLT treatment elevated cAMP and p-CREB levels, reduced amyloid-β (Aβ) accumulation, promoted synaptic function, and ameliorated mitochondrial fragmentation, along with mtDNA homeostasis in the AD cell model. Moreover, under conditions of mtDNA depletion or Drp1 overexpression, VLT exerted neuroprotective effects and maintained mtDNA homeostasis via the cAMP-PKA-CREB signaling pathway. These results demonstrate that PDE4 inhibition by VLT represents a promising therapeutic strategy for AD and related neurodegenerative disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou 570225, China.
ORCID-Profile: Wandi Xiong
Förderung
- Hainan Provincial Natural Science Foundation of China
- National Natural Science Foundation of China
- Natural Science Foundation of China
Zitieren
APA
Fu, T., Shi, Y., Yang, Z., Zhou, J., Huang, L., Fu, Y., & Xiong, W. (2026). Variecolactone, a Natural PDE4 Inhibitor from Marine-Derived Talaromyces sp. ZSD-1, Alleviates Amyloid-β Accumulation and mtDNA Dyshomeostasis via cAMP-PKA-CREB Signaling Pathway. Biomolecules, 16(4), 570. https://doi.org/10.3390/biom16040570
Vancouver
Fu T, Shi Y, Yang Z, Zhou J, Huang L, Fu Y, et al. Variecolactone, a Natural PDE4 Inhibitor from Marine-Derived Talaromyces sp. ZSD-1, Alleviates Amyloid-β Accumulation and mtDNA Dyshomeostasis via cAMP-PKA-CREB Signaling Pathway. Biomolecules. 2026;16(4):570. doi:10.3390/biom16040570
BibTeX
@article{Fu2026,
author = {Fu, Tingting and Shi, Yujia and Yang, Zhonglin and Zhou, Juan and Huang, Ling and Fu, Ying and Xiong, Wandi},
title = {Variecolactone, a Natural PDE4 Inhibitor from Marine-Derived Talaromyces sp. ZSD-1, Alleviates Amyloid-β Accumulation and mtDNA Dyshomeostasis via cAMP-PKA-CREB Signaling Pathway},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {4},
pages = {570},
doi = {10.3390/biom16040570}
}
EUVIMED